Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kah-Whye Peng

Showing results (51-60 of 116) with videos related to

Pageof 12
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2015
Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic VirusesAmber Miller, Rebecca Nace, Camilo Ayala-Breton C, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2016
Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor ModelHuailei Jiang, Aditya Bansal, Mukesh K Pandey, et al.
Nature Biotechnology|March 3, 2004
Antibody-targeted cell fusionTakafumi Nakamura, Kah-Whye Peng, Sompong Vongpunsawad, et al.
Nature Biotechnology|February 3, 2005
Rescue and propagation of fully retargeted oncolytic measles virusesTakafumi Nakamura, Kah-Whye Peng, Mary Harvey, et al.
The Journal of Gene Medicine|January 14, 2009
Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genomeLinh Pham, Takafumi Nakamura, A Gabriela Rosales, et al.
Journal of Virology|March 21, 2014
Vesiculovirus neutralization by natural IgM and complementMulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, et al.
Journal of Virology|August 13, 2010
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entryMatthew K Ennis, Chunling Hu, Shruthi K Naik, et al.
Human Gene Therapy. Clinical Development|September 9, 2016
Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko MiceSangeet Lal, Kah-Whye Peng, Michael B Steele, et al.
Journal of Virology|November 19, 2010
Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahariToshie Sakuma, Jason M Tonne, Karen A Squillace, et al.
Experimental Hematology|May 27, 2006
Oncolytic measles virus targets high CD46 expression on multiple myeloma cellsHooi Tin Ong, Michael M Timm, Philip R Greipp, et al.
Pageof 12

Showing results (51-60 of 116) with videos related to

Sort By:
Pageof 12
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 10, 2015
Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic VirusesAmber Miller, Rebecca Nace, Camilo Ayala-Breton C, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 23, 2016
Synthesis of 18F-Tetrafluoroborate via Radiofluorination of Boron Trifluoride and Evaluation in a Murine C6-Glioma Tumor ModelHuailei Jiang, Aditya Bansal, Mukesh K Pandey, et al.
Nature Biotechnology|March 3, 2004
Antibody-targeted cell fusionTakafumi Nakamura, Kah-Whye Peng, Sompong Vongpunsawad, et al.
Nature Biotechnology|February 3, 2005
Rescue and propagation of fully retargeted oncolytic measles virusesTakafumi Nakamura, Kah-Whye Peng, Mary Harvey, et al.
The Journal of Gene Medicine|January 14, 2009
Concordant activity of transgene expression cassettes inserted into E1, E3 and E4 cloning sites in the adenovirus genomeLinh Pham, Takafumi Nakamura, A Gabriela Rosales, et al.
Journal of Virology|March 21, 2014
Vesiculovirus neutralization by natural IgM and complementMulu Z Tesfay, Arun Ammayappan, Mark J Federspiel, et al.
Journal of Virology|August 13, 2010
Mutations in the stalk region of the measles virus hemagglutinin inhibit syncytium formation but not virus entryMatthew K Ennis, Chunling Hu, Shruthi K Naik, et al.
Human Gene Therapy. Clinical Development|September 9, 2016
Safety Study: Intraventricular Injection of a Modified Oncolytic Measles Virus into Measles-Immune, hCD46-Transgenic, IFNαRko MiceSangeet Lal, Kah-Whye Peng, Michael B Steele, et al.
Journal of Virology|November 19, 2010
Early events in retrovirus XMRV infection of the wild-derived mouse Mus pahariToshie Sakuma, Jason M Tonne, Karen A Squillace, et al.
Experimental Hematology|May 27, 2006
Oncolytic measles virus targets high CD46 expression on multiple myeloma cellsHooi Tin Ong, Michael M Timm, Philip R Greipp, et al.
Pageof 12